Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The current study was carried out to investigate the cognitive effects of two serotonin reuptake inhibitors (SSRIs), sertraline and paroxetine, with special reference to differences in their affinity for other neurotransmitter systems, i.e. anticholinergic activity of paroxetine and putative dopamine reuptake activity of sertraline. The study was conducted according to a double-blind, three-way cross-over design. During three treatment periods of 2 weeks, 24 healthy middle-aged (aged 30–50 years) subjects of both sexes received sertraline (50 mg on days 1–7, 100 mg on days 8–14), paroxetine (20 mg on days 1–7, 40 mg on days 8–14) and placebo. Paroxetine specifically impaired delayed recall in a word learning test at a dose of 20 and 40 mg. Sertraline did not affect word learning but improved performance on a verbal fluency task at a dose of 50 and 100 mg. Neither drug affected performance on a short-term memory scanning task. These subtle but significant changes in cognitive performance can be explained by subtle differences in pharmacological profiles of these SSRIs. The additional anticholinergic effects of paroxetine could account for its induction of long-term memory impairment. Similarly, the additional dopaminergic effects of sertraline could account for its induction of slightly improved verbal fluency. The impairing and facilitating cognitive effects of paroxetine and sertraline, respectively, may be more pronounced in the elderly depressed patient.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacological profile of antidepressants and related compounds at human monoamine transporters
Tatsumi, M., Groshan, K., Blakely, R. D., & Richelson, E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01393-9 · Cited by 939
Depression and memory impairment: A meta-analysis of the association, its pattern, and specificity.
Burt, D. B., Zembar, M. J., & Niederehe, G. (1995) · Psychological Bulletin · doi:10.1037/0033-2909.117.2.285 · Cited by 903
Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
Hyttel, J. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199403001-00004 · Cited by 492 · cited 3×
“vitro was found to be six times that of sertraline (Hyttel, 1994), c mparable to that of the TCA imipramine and higher than that of the TCA nortriptyline (Richelson, 1996).”
BackgroundTryptophan depletion in normal volunteers produces selective impairments in learning and memory
Park, S. B., Coull, J. T., McShane, R. H., Young, A. H., Sahakian, B. J., Robbins, T. W., & Cowen, P. J. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90089-2 · Cited by 310 · cited 1×
“The proportion of correctly recognized words (cr) and the proportion of falsely recognized (fr) constitute the non-parametric sensitivity measure: A′ = 1–1/4[fr/cr + (1 – cr)/(1 – fr)] (Pollack and Norman, 1964).”
BackgroundTryptophan depletion in normal volunteers produces selective impairment in memory consolidation.
Riedel, W. J., Klaassen, T., Deutz, N. E. P., van Someren, A., & van Praag, H. M. (1999) · Psychopharmacology · doi:10.1007/s002130050845 · Cited by 271
Self-citationSchmitt, J. A. J., Jorissen, B. L., Sobczak, S., van Boxtel, M. P. J., Hogervorst, E., Deutz, N. E. P., & Riedel, W. J. (2000) · Journal of Psychopharmacology · doi:10.1177/026988110001400102 · Cited by 227
Self-citationEffects of antidepressants on cognitive functions: a review
Amado-Boccara, I. (1995) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)00068-c · Cited by 206
Clinical and psychometric correlates of dopamine D2 binding in depression
SHAH, P. J., OGILVIE, A. D., GOODWIN, G. M., & EBMEIER, K. P. (1997) · Psychological Medicine · doi:10.1017/s0033291797005382 · Cited by 170
Caffeine attenuates scopolamine-induced memory impairment in humans
Reidel, W., Hogervorst, E., Leboux, R., Verhey, F., van Praag, H., & Jolles, J. (1995) · Psychopharmacology · doi:10.1007/bf02246090 · Cited by 152
Synaptic Effects of Antidepressants
RICHELSON, E. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199606002-00001 · Cited by 120 · cited 3×
“vitro was found to be six times that of sertraline (Hyttel, 1994), c mparable to that of the TCA imipramine and higher than that of the TCA nortriptyline (Richelson, 1996).”
Background
Cited by
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
The bright side of being blue: depression as an adaptation for analyzing complex problems.
Andrews, P. W., & Thomson, J. A. (2009) · Psychological Review · doi:10.1037/a0016242 · Cited by 549
Neurocognitive impairment in drug-free patients with major depressive disorder
Porter, R. J., Gallagher, P., Thompson, J. M., & Young, A. H. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.3.214 · Cited by 519
Depression and cognitive complaints following mild traumatic brain injury
Silver, J. M., McAllister, T. W., & Arciniegas, D. B. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08111676 · Cited by 315
“Paroxetine, also a potent inhibitor of CYP450, may impair cognitive function even in healthy adults, most likely as a result of its antimuscarinic effects (50).”
BackgroundSerotonin and Human Cognitive Performance
Schmitt, J., Wingen, M., Ramaekers, J., Evers, E., & Riedel, W. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777698909 · Cited by 259
Self-citation
Metadata
- Authors
- Schmitt, J. A. J., Kruizinga, M. J., & Riedel, W. J.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2001-05
- Volume
- 15
- Issue
- 3
- Pages
- 173-179
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2117744574
- Cited by
- 116
- References
- 11
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors. https://app.cochat.ai/papers/10.1177/026988110101500304
- The paper
- Schmitt, J. A. J., Kruizinga, M. J., & Riedel, W. J. (2001). Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors. Journal of Psychopharmacology. https://doi.org/10.1177/026988110101500304
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.